Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.53 USD | +2.00% | -11.56% | -78.75% |
May. 09 | AEON Biopharma, Inc. Provides Update on Development Pipeline | CI |
May. 03 | US Equity Markets Close Higher Friday Following Weak Jobs Report | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 58.17M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.98% |
1 day | -5.06% | ||
1 week | -9.64% | ||
Current month | -61.04% | ||
1 month | -78.23% | ||
3 months | -84.83% | ||
6 months | -68.15% | ||
Current year | -79.17% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1.53 | +2.00% | 59 552 |
24-05-16 | 1.5 | -5.06% | 57,789 |
24-05-15 | 1.58 | -3.07% | 105,758 |
24-05-14 | 1.63 | -2.98% | 46,281 |
24-05-13 | 1.68 | -2.89% | 83,190 |
Delayed Quote Nyse, May 16, 2024 at 04:00 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-79.17% | 58.17M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.44% | 22.28B | |
-11.90% | 22.41B | |
-5.24% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- AEON Stock